First Horizon Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.9K | Sell |
118
-106
| -47% | -$16.1K | ﹤0.01% | 1464 |
|
|
2025
Q1 | $33.7K | Sell |
224
-14
| -6% | -$2.11K | ﹤0.01% | 1104 |
|
|
2024
Q4 | $43.9K | Sell |
238
-50
| -17% | -$9.23K | ﹤0.01% | 1003 |
|
|
2024
Q3 | $56.7K | Buy |
288
+8
| +3% | +$1.58K | ﹤0.01% | 932 |
|
|
2024
Q2 | $57.8K | Sell |
280
-24
| -8% | -$4.96K | ﹤0.01% | 859 |
|
|
2024
Q1 | $82.4K | Hold |
304
| – | – | ﹤0.01% | 748 |
|
|
2023
Q4 | $71.9K | Buy |
304
+7
| +2% | +$1.66K | ﹤0.01% | 773 |
|
|
2023
Q3 | $58.2K | Buy |
297
+10
| +3% | +$1.96K | ﹤0.01% | 795 |
|
|
2023
Q2 | $60.3K | Sell |
287
-20
| -7% | -$4.21K | ﹤0.01% | 808 |
|
|
2023
Q1 | $62K | Buy |
307
+65
| +27% | +$13.1K | ﹤0.01% | 798 |
|
|
2022
Q4 | $52.7K | Sell |
242
-6
| -2% | -$1.31K | ﹤0.01% | 838 |
|
|
2022
Q3 | $48K | Sell |
248
-5
| -2% | -$968 | ﹤0.01% | 852 |
|
|
2022
Q2 | $54K | Buy |
253
+133
| +111% | +$28.4K | ﹤0.01% | 901 |
|
|
2022
Q1 | $34K | Sell |
120
-73
| -38% | -$20.7K | ﹤0.01% | 741 |
|
|
2021
Q4 | $72K | Buy |
193
+38
| +25% | +$14.2K | ﹤0.01% | 792 |
|
|
2021
Q3 | $62K | Buy |
155
+122
| +370% | +$48.8K | ﹤0.01% | 822 |
|
|
2021
Q2 | $11K | Buy |
33
+13
| +65% | +$4.33K | ﹤0.01% | 1307 |
|
|
2021
Q1 | $5K | Buy |
20
+5
| +33% | +$1.25K | ﹤0.01% | 1446 |
|
|
2020
Q4 | $3K | Buy |
+15
| New | +$3K | ﹤0.01% | 1273 |
|